The Current Ratio as of September 2024 (TTM) for Soleno Therapeutics, Inc. (SLNO) is 29.24

According to Soleno Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 29.24. This represents a change of 104.40% compared to the average of 14.30 of the last 4 quarters.

Soleno Therapeutics, Inc. (SLNO) Historical Current Ratio (quarterly & annually)

How has SLNO Current Ratio performed in the past?

The mean historical Current Ratio of Soleno Therapeutics, Inc. over the last ten years is 6.41. The current 29.24 Current Ratio has changed 45.47% with respect to the historical average. Over the past ten years (40 quarters), SLNO's Current Ratio was at its highest in in the June 2024 quarter at 29.24. The Current Ratio was at its lowest in in the September 2014 quarter at 0.19.

Soleno Therapeutics, Inc. (SLNO) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Soleno Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Soleno Therapeutics, Inc. (SLNO) Average Current Ratio

How has SLNO Current Ratio performed in the past?

The current Current Ratio of Soleno Therapeutics, Inc. (SLNO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Soleno Therapeutics, Inc. (SLNO) Current Ratio vs. Peers

How is SLNO’s Current Ratio compared to its peers?

Soleno Therapeutics, Inc.’s Current Ratio is greater than Annexon, Inc. (21.81), greater than Icosavax, Inc. (18.06), greater than VectivBio Holding AG (9.14), greater than Bolt Biotherapeutics, Inc. (4.28), greater than Lyra Therapeutics, Inc. (3.60), greater than Pulmatrix, Inc. (6.33), greater than Capricor Therapeutics, Inc. (1.37), greater than Akari Therapeutics, Plc (0.58), greater than Diffusion Pharmaceuticals Inc. (10.96), greater than Onconova Therapeutics, Inc. (1.93), greater than Catalyst Biosciences, Inc. (0), greater than Bio-Path Holdings, Inc. (1.67), greater than Moleculin Biotech, Inc. (2.39), greater than Day One Biopharmaceuticals, Inc. (4.09), greater than Acumen Pharmaceuticals, Inc. (17.37), greater than X4 Pharmaceuticals, Inc. (6.07), greater than Inozyme Pharma, Inc. (9.84), greater than Applied Molecular Transport Inc. (4.99), greater than Aileron Therapeutics, Inc. (4.69), greater than Benitec Biopharma Inc. (4.18),

Build a custom stock screener for Soleno Therapeutics, Inc. (SLNO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Soleno Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Soleno Therapeutics, Inc. (SLNO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Soleno Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.